世界のトキソプラズマ症診断検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Toxoplasmosis Diagnostic Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4966 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、トキソプラズマ症診断検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（間接免疫蛍光試験（IFAT）、修正凝集試験（MAT）、酵素免疫測定法（ELISA）、免疫グロブリン試験）、用途別市場規模（病院、診療所、診断研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・トキソプラズマ症診断検査の市場動向 ・企業の競争状況、市場シェア ・トキソプラズマ症診断検査の種類別市場規模と予測2016-2027（間接免疫蛍光試験（IFAT）、修正凝集試験（MAT）、酵素免疫測定法（ELISA）、免疫グロブリン試験） ・トキソプラズマ症診断検査の用途別市場規模と予測2016-2027（病院、診療所、診断研究所、その他） ・トキソプラズマ症診断検査の北米市場規模2016-2027（アメリカ、カナダ） ・トキソプラズマ症診断検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・トキソプラズマ症診断検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・トキソプラズマ症診断検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・トキソプラズマ症診断検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Thermo Fisher Scientific、Bio-Rad、Danaher、Biomerica、Biotest、GenBio） ・結論

Market Analysis and Insights: Global Toxoplasmosis Diagnostic Testing Market
The global Toxoplasmosis Diagnostic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Toxoplasmosis Diagnostic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Toxoplasmosis Diagnostic Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Toxoplasmosis Diagnostic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Toxoplasmosis Diagnostic Testing market.

Global Toxoplasmosis Diagnostic Testing Scope and Market Size
Toxoplasmosis Diagnostic Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Toxoplasmosis Diagnostic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Indirect Immune Fluorescent Test (IFAT)
Modified Agglutination Test (MAT)
Enzyme-Linked Immunosorbent Assay (ELISA)
Immunoglobulin Tests

Segment by Application
Hospitals
Clinics
Diagnostic Laboratories
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Thermo Fisher Scientific
Bio-Rad
Danaher
Biomerica
Biotest
GenBio

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Toxoplasmosis Diagnostic Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Indirect Immune Fluorescent Test (IFAT)
1.2.3 Modified Agglutination Test (MAT)
1.2.4 Enzyme-Linked Immunosorbent Assay (ELISA)
1.2.5 Immunoglobulin Tests
1.3 Market by Application
1.3.1 Global Toxoplasmosis Diagnostic Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Toxoplasmosis Diagnostic Testing Market Perspective (2016-2027)
2.2 Toxoplasmosis Diagnostic Testing Growth Trends by Regions
2.2.1 Toxoplasmosis Diagnostic Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Toxoplasmosis Diagnostic Testing Historic Market Share by Regions (2016-2021)
2.2.3 Toxoplasmosis Diagnostic Testing Forecasted Market Size by Regions (2022-2027)
2.3 Toxoplasmosis Diagnostic Testing Industry Dynamic
2.3.1 Toxoplasmosis Diagnostic Testing Market Trends
2.3.2 Toxoplasmosis Diagnostic Testing Market Drivers
2.3.3 Toxoplasmosis Diagnostic Testing Market Challenges
2.3.4 Toxoplasmosis Diagnostic Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Toxoplasmosis Diagnostic Testing Players by Revenue
3.1.1 Global Top Toxoplasmosis Diagnostic Testing Players by Revenue (2016-2021)
3.1.2 Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Players (2016-2021)
3.2 Global Toxoplasmosis Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Toxoplasmosis Diagnostic Testing Revenue
3.4 Global Toxoplasmosis Diagnostic Testing Market Concentration Ratio
3.4.1 Global Toxoplasmosis Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Toxoplasmosis Diagnostic Testing Revenue in 2020
3.5 Toxoplasmosis Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players Toxoplasmosis Diagnostic Testing Product Solution and Service
3.7 Date of Enter into Toxoplasmosis Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Toxoplasmosis Diagnostic Testing Breakdown Data by Type
4.1 Global Toxoplasmosis Diagnostic Testing Historic Market Size by Type (2016-2021)
4.2 Global Toxoplasmosis Diagnostic Testing Forecasted Market Size by Type (2022-2027)

5 Toxoplasmosis Diagnostic Testing Breakdown Data by Application
5.1 Global Toxoplasmosis Diagnostic Testing Historic Market Size by Application (2016-2021)
5.2 Global Toxoplasmosis Diagnostic Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Toxoplasmosis Diagnostic Testing Market Size (2016-2027)
6.2 North America Toxoplasmosis Diagnostic Testing Market Size by Type
6.2.1 North America Toxoplasmosis Diagnostic Testing Market Size by Type (2016-2021)
6.2.2 North America Toxoplasmosis Diagnostic Testing Market Size by Type (2022-2027)
6.2.3 North America Toxoplasmosis Diagnostic Testing Market Size by Type (2016-2027)
6.3 North America Toxoplasmosis Diagnostic Testing Market Size by Application
6.3.1 North America Toxoplasmosis Diagnostic Testing Market Size by Application (2016-2021)
6.3.2 North America Toxoplasmosis Diagnostic Testing Market Size by Application (2022-2027)
6.3.3 North America Toxoplasmosis Diagnostic Testing Market Size by Application (2016-2027)
6.4 North America Toxoplasmosis Diagnostic Testing Market Size by Country
6.4.1 North America Toxoplasmosis Diagnostic Testing Market Size by Country (2016-2021)
6.4.2 North America Toxoplasmosis Diagnostic Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Toxoplasmosis Diagnostic Testing Market Size (2016-2027)
7.2 Europe Toxoplasmosis Diagnostic Testing Market Size by Type
7.2.1 Europe Toxoplasmosis Diagnostic Testing Market Size by Type (2016-2021)
7.2.2 Europe Toxoplasmosis Diagnostic Testing Market Size by Type (2022-2027)
7.2.3 Europe Toxoplasmosis Diagnostic Testing Market Size by Type (2016-2027)
7.3 Europe Toxoplasmosis Diagnostic Testing Market Size by Application
7.3.1 Europe Toxoplasmosis Diagnostic Testing Market Size by Application (2016-2021)
7.3.2 Europe Toxoplasmosis Diagnostic Testing Market Size by Application (2022-2027)
7.3.3 Europe Toxoplasmosis Diagnostic Testing Market Size by Application (2016-2027)
7.4 Europe Toxoplasmosis Diagnostic Testing Market Size by Country
7.4.1 Europe Toxoplasmosis Diagnostic Testing Market Size by Country (2016-2021)
7.4.2 Europe Toxoplasmosis Diagnostic Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size (2016-2027)
8.2 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Type
8.2.1 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Application
8.3.1 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Region
8.4.1 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Toxoplasmosis Diagnostic Testing Market Size (2016-2027)
9.2 Latin America Toxoplasmosis Diagnostic Testing Market Size by Type
9.2.1 Latin America Toxoplasmosis Diagnostic Testing Market Size by Type (2016-2021)
9.2.2 Latin America Toxoplasmosis Diagnostic Testing Market Size by Type (2022-2027)
9.2.3 Latin America Toxoplasmosis Diagnostic Testing Market Size by Type (2016-2027)
9.3 Latin America Toxoplasmosis Diagnostic Testing Market Size by Application
9.3.1 Latin America Toxoplasmosis Diagnostic Testing Market Size by Application (2016-2021)
9.3.2 Latin America Toxoplasmosis Diagnostic Testing Market Size by Application (2022-2027)
9.3.3 Latin America Toxoplasmosis Diagnostic Testing Market Size by Application (2016-2027)
9.4 Latin America Toxoplasmosis Diagnostic Testing Market Size by Country
9.4.1 Latin America Toxoplasmosis Diagnostic Testing Market Size by Country (2016-2021)
9.4.2 Latin America Toxoplasmosis Diagnostic Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size (2016-2027)
10.2 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Type
10.2.1 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Application
10.3.1 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Country
10.4.1 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Toxoplasmosis Diagnostic Testing Introduction
11.1.4 Abbott Revenue in Toxoplasmosis Diagnostic Testing Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Toxoplasmosis Diagnostic Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Toxoplasmosis Diagnostic Testing Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Details
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Toxoplasmosis Diagnostic Testing Introduction
11.3.4 Bio-Rad Revenue in Toxoplasmosis Diagnostic Testing Business (2016-2021)
11.3.5 Bio-Rad Recent Development
11.4 Danaher
11.4.1 Danaher Company Details
11.4.2 Danaher Business Overview
11.4.3 Danaher Toxoplasmosis Diagnostic Testing Introduction
11.4.4 Danaher Revenue in Toxoplasmosis Diagnostic Testing Business (2016-2021)
11.4.5 Danaher Recent Development
11.5 Biomerica
11.5.1 Biomerica Company Details
11.5.2 Biomerica Business Overview
11.5.3 Biomerica Toxoplasmosis Diagnostic Testing Introduction
11.5.4 Biomerica Revenue in Toxoplasmosis Diagnostic Testing Business (2016-2021)
11.5.5 Biomerica Recent Development
11.6 Biotest
11.6.1 Biotest Company Details
11.6.2 Biotest Business Overview
11.6.3 Biotest Toxoplasmosis Diagnostic Testing Introduction
11.6.4 Biotest Revenue in Toxoplasmosis Diagnostic Testing Business (2016-2021)
11.6.5 Biotest Recent Development
11.7 GenBio
11.7.1 GenBio Company Details
11.7.2 GenBio Business Overview
11.7.3 GenBio Toxoplasmosis Diagnostic Testing Introduction
11.7.4 GenBio Revenue in Toxoplasmosis Diagnostic Testing Business (2016-2021)
11.7.5 GenBio Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Toxoplasmosis Diagnostic Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Indirect Immune Fluorescent Test (IFAT)
Table 3. Key Players of Modified Agglutination Test (MAT)
Table 4. Key Players of Enzyme-Linked Immunosorbent Assay (ELISA)
Table 5. Key Players of Immunoglobulin Tests
Table 6. Global Toxoplasmosis Diagnostic Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Toxoplasmosis Diagnostic Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Toxoplasmosis Diagnostic Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Toxoplasmosis Diagnostic Testing Market Share by Regions (2016-2021)
Table 10. Global Toxoplasmosis Diagnostic Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Toxoplasmosis Diagnostic Testing Market Share by Regions (2022-2027)
Table 12. Toxoplasmosis Diagnostic Testing Market Trends
Table 13. Toxoplasmosis Diagnostic Testing Market Drivers
Table 14. Toxoplasmosis Diagnostic Testing Market Challenges
Table 15. Toxoplasmosis Diagnostic Testing Market Restraints
Table 16. Global Toxoplasmosis Diagnostic Testing Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Toxoplasmosis Diagnostic Testing Market Share by Players (2016-2021)
Table 18. Global Top Toxoplasmosis Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Toxoplasmosis Diagnostic Testing as of 2020)
Table 19. Ranking of Global Top Toxoplasmosis Diagnostic Testing Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Toxoplasmosis Diagnostic Testing Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Toxoplasmosis Diagnostic Testing Product Solution and Service
Table 23. Date of Enter into Toxoplasmosis Diagnostic Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Toxoplasmosis Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Type (2016-2021)
Table 27. Global Toxoplasmosis Diagnostic Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Toxoplasmosis Diagnostic Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Application (2016-2021)
Table 31. Global Toxoplasmosis Diagnostic Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Toxoplasmosis Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Toxoplasmosis Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Toxoplasmosis Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Toxoplasmosis Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Toxoplasmosis Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Toxoplasmosis Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Toxoplasmosis Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Toxoplasmosis Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Toxoplasmosis Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Toxoplasmosis Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Toxoplasmosis Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Toxoplasmosis Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Toxoplasmosis Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Toxoplasmosis Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Toxoplasmosis Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Toxoplasmosis Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Toxoplasmosis Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Toxoplasmosis Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Toxoplasmosis Diagnostic Testing Product
Table 66. Abbott Revenue in Toxoplasmosis Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 67. Abbott Recent Development
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Toxoplasmosis Diagnostic Testing Product
Table 71. Thermo Fisher Scientific Revenue in Toxoplasmosis Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Development
Table 73. Bio-Rad Company Details
Table 74. Bio-Rad Business Overview
Table 75. Bio-Rad Toxoplasmosis Diagnostic Testing Product
Table 76. Bio-Rad Revenue in Toxoplasmosis Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 77. Bio-Rad Recent Development
Table 78. Danaher Company Details
Table 79. Danaher Business Overview
Table 80. Danaher Toxoplasmosis Diagnostic Testing Product
Table 81. Danaher Revenue in Toxoplasmosis Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 82. Danaher Recent Development
Table 83. Biomerica Company Details
Table 84. Biomerica Business Overview
Table 85. Biomerica Toxoplasmosis Diagnostic Testing Product
Table 86. Biomerica Revenue in Toxoplasmosis Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 87. Biomerica Recent Development
Table 88. Biotest Company Details
Table 89. Biotest Business Overview
Table 90. Biotest Toxoplasmosis Diagnostic Testing Product
Table 91. Biotest Revenue in Toxoplasmosis Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 92. Biotest Recent Development
Table 93. GenBio Company Details
Table 94. GenBio Business Overview
Table 95. GenBio Toxoplasmosis Diagnostic Testing Product
Table 96. GenBio Revenue in Toxoplasmosis Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 97. GenBio Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Toxoplasmosis Diagnostic Testing Market Share by Type: 2020 VS 2027
Figure 2. Indirect Immune Fluorescent Test (IFAT) Features
Figure 3. Modified Agglutination Test (MAT) Features
Figure 4. Enzyme-Linked Immunosorbent Assay (ELISA) Features
Figure 5. Immunoglobulin Tests Features
Figure 6. Global Toxoplasmosis Diagnostic Testing Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Diagnostic Laboratories Case Studies
Figure 10. Others Case Studies
Figure 11. Toxoplasmosis Diagnostic Testing Report Years Considered
Figure 12. Global Toxoplasmosis Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Toxoplasmosis Diagnostic Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Toxoplasmosis Diagnostic Testing Market Share by Regions: 2020 VS 2027
Figure 15. Global Toxoplasmosis Diagnostic Testing Market Share by Regions (2022-2027)
Figure 16. Global Toxoplasmosis Diagnostic Testing Market Share by Players in 2020
Figure 17. Global Top Toxoplasmosis Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Toxoplasmosis Diagnostic Testing as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Toxoplasmosis Diagnostic Testing Revenue in 2020
Figure 19. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Type (2016-2021)
Figure 20. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Type (2022-2027)
Figure 21. North America Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Toxoplasmosis Diagnostic Testing Market Share by Type (2016-2027)
Figure 23. North America Toxoplasmosis Diagnostic Testing Market Share by Application (2016-2027)
Figure 24. North America Toxoplasmosis Diagnostic Testing Market Share by Country (2016-2027)
Figure 25. United States Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Toxoplasmosis Diagnostic Testing Market Share by Type (2016-2027)
Figure 29. Europe Toxoplasmosis Diagnostic Testing Market Share by Application (2016-2027)
Figure 30. Europe Toxoplasmosis Diagnostic Testing Market Share by Country (2016-2027)
Figure 31. Germany Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Share by Region (2016-2027)
Figure 41. China Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Toxoplasmosis Diagnostic Testing Market Share by Type (2016-2027)
Figure 49. Latin America Toxoplasmosis Diagnostic Testing Market Share by Application (2016-2027)
Figure 50. Latin America Toxoplasmosis Diagnostic Testing Market Share by Country (2016-2027)
Figure 51. Mexico Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Share by Country (2016-2027)
Figure 57. Turkey Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2016-2021)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2016-2021)
Figure 62. Bio-Rad Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2016-2021)
Figure 63. Danaher Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2016-2021)
Figure 64. Biomerica Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2016-2021)
Figure 65. Biotest Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2016-2021)
Figure 66. GenBio Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---